Q1 2022 ADC Therapeutics SA Earnings Call Transcript
Welcome to the ADC Therapeutics First Quarter 2022 Financial Results Conference Call. My name is Michelle, and I will be the operator for today's call. (Operator Instructions)
I will now turn the call over to Amanda Hamilton, Investor Relations Manager. Amanda, you may begin.
Thank you, operator. This morning, we issued a press release announcing our first quarter 2022 financial results and business update. This release is available on the ADCT website at ir.adctherapeutics.com under the Press Releases section. On today's call, Chris Martin, former Chief Executive Officer; Jennifer Herron, Chief Commercial Officer; Joe Camardo, Chief Medical Officer; and Jenn Creel, Chief Financial Officer, will discuss recent business highlights and review our first quarter 2022 financial results before opening the call for questions. We will also have a brief introduction from our new Chief Executive Officer, Ameet Mallik.
As a reminder, this conference call may contain forward-looking statements. Such
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |